Centers of Excellence for Influenza Research and Surveillance (CEIRS)

Publications

(Updated August 5, 2009)

Emory University: Influenza Pathogenesis and Immunology Research Center (IPIRC)

Thoennes S, et. al. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.Virology.2008 Jan 20;370(2):403-14. Epub 2007 Oct 23.

Song X et al. Novel Fluorescent Glycan Microarray Strategy Reveals Ligands for Galectins. Chem Biol. 2009 Jan 30;16(1):36-47.

Mundt E et al. Replication and pathogenesis associated with H5N1, H5N2 and H5N3 low pathogenic avian influenza virus infection in chickens and ducks. Arch Virol. 2009 Jul 3..

Smith K et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nature protocols 4, 372-384 (2009)

Thoennes S et al.. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.

Salomon R et al. The Influenza virus enigma. Cell. 2009 Feb 6; 136(3):402-410.

Forrest HL et al. Single- and multiple-clade influenza A H5N1 vaccines induce crossprotection in ferrets. Vaccine. Volume 27, Issue 31, 24 June 2009, Pages 4187-4195

Bahl J et al. Gene flow and competitive exclusion in avian influenza A virus. Virology. 2009 Aug 1;390(2):289-97. Epub 2009 Jun 5.

Marjuki H et al. Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons 31(Falco cherrug) in the Middle East. Advances in Virology, Volume 2009 (2009), Article ID 294520; doi:10.1155/2009/294520.

Lee JH et al. Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol. 2009 Feb 18.

Santhia K et al. Avian influenza A H5N1 infections in Bali province, Indonesia: a behavioral, virological and seroepidemiological study.

Influenza Other Respi Viruses. 2009 May;3(3):81-9

Zhu HC et al. Detection of diverse astroviruses from bats in China. Journal of General Virology 90: 883–887.

Smith GJD et al. Characterization of Avian Influenza Viruses A (H5N1) from Wild Birds, Hong Kong, 2004-2008. Emerging Infectious Diseases 15: 402–407.

Ellis TM et al. Analysis of H5N1 avian influenza infections from wild bird surveillance in Hong Kong from January 2006 to October 2007. Avian Pathology 38: 107–119.

Govorkova EA et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrobial Agents and Chemotherapy, July 2009, p. 3088-3096, Vol. 53, No. 7

Varich NL et al. Location of antigenic sites recognized by monoclonal 74 antibodies in the influenza A virus nucleoprotein molecule. J Gen Virol. 2009 Mar18.

Wan H et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential.PLoS ONE Aug 12; 3(8): e2923.

Ma W et al. The pig as a mixing vessel for influenza viruses: Human and Veterinary Implications. Journal of Molecular and Genetic Medicine. 3(1), 158-166. (PDF)

Li OT et al. A Full Factorial Analysis of Compatibility between Mammalian and Avian Influenza Polymerase Subunits.

PLoS ONE 4(5): e5658. doi:10.1371/journal.pone.0005658

Aldridge, JR Jr. et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):5306-11. Epub 2009 Mar 11.

Reed, ML et al. Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. Journal of Virology, April 2009, p. 3568-3580, Vol. 83, No. 8.

Yen HL et al. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):286-91. Epub 2008 Dec 30.

Khalenkov A et al. Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses.
Virology. 2009 Jan 5;383(1):32-8. Epub 2008 Nov 7.

Sandbulte MR et al. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses.
Virology. 2008 Nov 10;381(1):22-8. Epub 2008 Sep 17.

Ilyushina NA et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.
Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97. Epub 2008 Aug 25.

Boltz DA et al. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
Antiviral Res. 2008 Nov;80(2):150-7. Epub 2008 Jun 23.

Kim JK et al. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.
J Virol. 2008 Nov;82(22):11374-82. Epub 2008 Sep 10.

Duan L et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006.
Virology. 2008 Oct 25;380(2):243-54. Epub 2008 Sep 6.

Vijaykrishna D et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses.
PLoS Pathog. 2008 Sep 26;4(9):e1000161.

Kim JK et al. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.
J Virol. 2008 Nov;82(22):11374-82. Epub 2008 Sep 10.

Duan L et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006.
Virology. 2008 Oct 25;380(2):243-54. Epub 2008 Sep 6.

Ilyushina NA et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.
Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97. Epub 2008 Aug 25.

Marjuki H et al. CK2beta gene silencing increases cell susceptibility to influenza A virus infection resulting in accelerated virus entry and higher viral protein content.
J Mol Signal. 2008 Jul 23;3:13.

Boltz DA et al. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
Antiviral Res. 2008 Nov;80(2):150-7. Epub 2008 Jun 23.

Chu DK et al. Novel astroviruses in insectivorous bats.
J Virol. 2008 Sep;82(18):9107-14. Epub 2008 Jun 11.

Al-Azemi A et al. Avian influenza A virus (H5N1) outbreaks, Kuwait, 2007.
Emerg Infect Dis. 2008 Jun;14(6):958-61.

Chu DK et al. Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats.
J Gen Virol. 2008 May;89(Pt 5):1282-7.

Boltz DA et al. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model.
J Infect Dis. 2008 May 1;197(9):1315-23.

Ilyushina NA et al. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
PLoS Pathog. 2008 Apr 11;4(4):e1000043.

Dung Nguyen T et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007.
Emerg Infect Dis. 2008 Apr;14(4):632-6.

Wang J et al. Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China.
J Virol. 2008 Apr;82(7):3405-14. Epub 2008 Jan 23.

Khalenkov A et al. Detection and isolation of H5N1 influenza virus from large volumes of natural water.
J Virol Methods. 2008 Apr;149(1):180-3. Epub 2008 Mar 5.

Ng SS et al. Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans.
Virol J. 2008 Jan 11;5:2.

Lipatov AS et al. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.
Arch Virol. 2008;153(3):427-34. Epub 2007 Dec 4.

Ma W et al. Identification of H2N3 influenza A viruses from swine in the United States.
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20949-54. Epub 2007 Dec 18.

Marjuki H et al. Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade.
Virol J. 2007 Dec 5;4:134.

Kaverin NV et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
J Virol. 2007 Dec;81(23):12911-7. Epub 2007 Sep 19.

Boon AC et al. Role of terrestrial wild birds in ecology of influenza A virus (H5N1).
Emerg Infect Dis. 2007 Nov;13(11):1720-4.

Yen HL et al. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
J Virol. 2007 Nov;81(22):12418-26. Epub 2007 Sep 12.

Fasina FO et al. Avian influenza H5N1 in Africa: an epidemiological twist.
Lancet Infect Dis. 2007 Nov;7(11):696-7. No abstract available.

Krauss S et al. Influenza in migratory birds and evidence of limited intercontinental virus exchange.
PLoS Pathog. 2007 Nov;3(11):e167.

Xu KM et al. The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005.
J Virol. 2007 Oct;81(19):10389-401. Epub 2007 Jul 25.

Cheung CL et al. Establishment of influenza A virus (H6N1) in minor poultry species in southern China.
J Virol. 2007 Oct;81(19):10402-12. Epub 2007 Jul 25.

Leung YH et al. Poultry drinking water used for avian influenza surveillance.
Emerg Infect Dis. 2007 Sep;13(9):1380-2.

Salomon R et al. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus.
Cell Cycle. 2007 Aug;6(19):2417-21. Epub 2007 Jul 22.

Salomon R et al. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection.
Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12479-81. Epub 2007 Jul 17.

Duan L et al. Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses.
J Virol. 2007 Jul;81(14):7529-39. Epub 2007 May 16.

Yen HL et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model.
J Virol. 2007 Jul;81(13):6890-8. Epub 2007 Apr 25.

Evseenko VA et al. Diversity of highly pathogenic avian influenza H5N1 viruses that caused epizootic in Western Siberia in 2005.
Dokl Biol Sci. 2007 May-Jun;414:226-30. No abstract available.

Aamir UB et al. Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003.
Virology. 2007 Apr 25;361(1):45-55. Epub 2006 Dec 8.

Humberd J et al. Emergence of influenza A virus variants after prolonged shedding from pheasants.
J Virol. 2007 Apr;81(8):4044-51. Epub 2007 Jan 31.

Lee YJ et al. Continuing evolution of H9 influenza viruses in Korean poultry.
Virology. 2007 Mar 15;359(2):313-23. Epub 2006 Oct 23.

Kumar M et al. Association of serologic and protective responses of avian influenza vaccines in chickens.
Avian Dis. 2007 Mar;51(1 Suppl):481-3.

Xu KM et al. Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005.
J Virol. 2007 Mar;81(6):2635-45. Epub 2006 Dec 27.

Ilyushina NA et al. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Antivir Ther. 2007;12(3):363-70.

Boltz DA et al. H5N1 influenza viruses in Lao People's Democratic Republic.
Emerg Infect Dis. 2006 Oct;12(10):1593-5.

University of Minnesota: Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS)

Brown JD, et al. Evaluation of a commercial blocking enzyme-linked immunosorbent assay to detect avian influenza virus antibodies in multiple experimentally infected avian species. Clinical and Vaccine Immunology 2009; 16: 824-829.

Suwannakarn K et al. Molecular evolution of H5N1 in Thailand between 2004 and 2008. Infection, Genetics and Evolution. 2009 (in press)

Naresh Jindal et al. Amplification of four genes of influenza A viruses using a degenerate primer set in a one step RT-PCR method. J Virol Methods. 2009 Sep;160(1-2):163-6. Epub 2009 May 15.

University of Rochester: The New York Influenza Center of Excellence (NYICE)

Elphick GF et al. Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood, 23 April 2009, Vol. 113, No. 17, pp. 4078-4085.

Crompton PD et al. The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J Immunol, 2009, 182:3318-3326.

Bancos S et al. Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol. 2009;258(1):18-28. Epub 2009 Apr 5.

Weaver JM et al. Abortive activation of CD4 T cell responses under conditions of competitive priming in vivo. PNAS May 26, 2009 vol. 106 no. 21 8647-8652

Richards KA et al. Infection of HLA-DR1 transgenic mice with a human isolate of influenza A (H1N1) primes a diverse CD4 T cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza. Journal of Virology, July 2009, p. 6566-6577, Vol. 83, No. 13.

Weaver JM et al. Understanding the focused CD4 T cell response to antigen and pathogenic organisms. Immunol Res. 2009 Feb 7.

Coli DA et al. Enhancement of enveloped virus entry by phosphoserine. J. Virol. 79, 11496-11500, 2005.

Elander G et al. Functionalisation of Si/SiO2 and glass surfaces with ultrathin dextran films and deposition of lipid bilayers. Biosensors & Bioelectronics, 11, 565-577, 1996.

Yang T et al. Fabrication of Phospholipid Bilayer-coated Microchannels for On-chip Immunoassays. Analytical Chemistry, 73, 165-169, 2001.

Bradel-Tretheway BG, et al. The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit. J Gen Virol. 2008 Dec; 89(Pt 12):2923-32

Kyu SY et al. Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells.
J Immunol Methods. 2009 Jan 1;340(1):42-7. Epub 2008 Nov 6.

Weaver JM et al. Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.
J Immunol. 2008 Sep 1;181(5):3039-48.

Order Publications

NIAID Publications order form

back to top